Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1019 | 1008 | 1116 | 1084 | 1194 | 1490 |
Fund Return | 1.85% | 0.82% | 11.58% | 2.72% | 3.61% | 4.07% |
Place in category | 195 | 351 | 88 | 25 | 13 | 7 |
% in Category | 21 | 36 | 11 | 5 | 3 | 1 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS Lux Bond SICAV Convert Global q | 3.79B | 0.79 | -3.61 | 3.85 | ||
UBS Lux Bond SICAV Convert Global E | 3.79B | 1.11 | -2.85 | 4.84 | ||
UBS Bond S Convert Global EUR F Acc | 3.79B | 0.91 | -3.23 | 4.37 | ||
UBS Bond S Convert Global EUR hedge | 3.79B | 1.11 | -2.85 | 4.84 | ||
UBS Bond S Convert Global EUR I A1 | 3.79B | 0.86 | -3.56 | 4.17 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nordea 1 European High Yield Bond x | 2.77B | 1.70 | 1.27 | 3.94 | ||
LU0229519474 | 2.77B | 1.01 | -0.75 | 1.87 | ||
N1 European High Yield Bond Fund AC | 2.77B | 1.40 | 0.43 | 3.07 | ||
N1 European High Yield Bond Fund Ai | 2.77B | 1.48 | 0.61 | 3.28 | ||
N1 European High Yield Bond Fund Ae | 2.77B | 1.27 | 0.00 | 2.64 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Teva Pharmaceutical Finance Netherlands II B.V 7.375% | XS2592804434 | 1.57 | - | - | |
Nidda Healthcare Holding GmbH 7.5% | XS2550063478 | 1.51 | - | - | |
Btp Tf 3,75% St24 Eur | IT0005001547 | 1.28 | 100.01 | -0.01% | |
Altice France S.A 5.875% | XS1859337419 | 1.20 | - | - | |
Barclays PLC 0% | - | 1.08 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review